nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ABCG2—hematologic cancer	0.085	0.417	CbGaD
Tamoxifen—ESR1—hematologic cancer	0.0833	0.409	CbGaD
Tamoxifen—DHCR7—Epirubicin—hematologic cancer	0.0361	0.0722	CbGbCtD
Tamoxifen—ABCB1—hematologic cancer	0.0354	0.174	CbGaD
Tamoxifen—CYP1B1—Procarbazine—hematologic cancer	0.0217	0.0434	CbGbCtD
Tamoxifen—DHCR7—Doxorubicin—hematologic cancer	0.0192	0.0384	CbGbCtD
Tamoxifen—FMO3—Dasatinib—hematologic cancer	0.0187	0.0375	CbGbCtD
Tamoxifen—ABCB11—Daunorubicin—hematologic cancer	0.0116	0.0233	CbGbCtD
Tamoxifen—CYP1B1—Daunorubicin—hematologic cancer	0.0116	0.0233	CbGbCtD
Tamoxifen—CES1—Irinotecan—hematologic cancer	0.00969	0.0194	CbGbCtD
Tamoxifen—ABCG2—Clofarabine—hematologic cancer	0.00943	0.0189	CbGbCtD
Tamoxifen—CYP1B1—Dasatinib—hematologic cancer	0.00715	0.0143	CbGbCtD
Tamoxifen—CYP1B1—Mitoxantrone—hematologic cancer	0.00707	0.0141	CbGbCtD
Tamoxifen—CYP2A6—Methoxsalen—hematologic cancer	0.00656	0.0131	CbGbCtD
Tamoxifen—ABCC2—Daunorubicin—hematologic cancer	0.00611	0.0122	CbGbCtD
Tamoxifen—CYP1A2—Anagrelide—hematologic cancer	0.00561	0.0112	CbGbCtD
Tamoxifen—CYP1A1—Methoxsalen—hematologic cancer	0.00561	0.0112	CbGbCtD
Tamoxifen—ABCG2—Daunorubicin—hematologic cancer	0.00553	0.0111	CbGbCtD
Tamoxifen—CYP2B6—Thiotepa—hematologic cancer	0.00549	0.011	CbGbCtD
Tamoxifen—CYP1A1—Bortezomib—hematologic cancer	0.00533	0.0107	CbGbCtD
Tamoxifen—CYP19A1—Betamethasone—hematologic cancer	0.00511	0.0102	CbGbCtD
Tamoxifen—CYP1A1—Daunorubicin—hematologic cancer	0.0051	0.0102	CbGbCtD
Tamoxifen—ABCB11—Vinblastine—hematologic cancer	0.00495	0.0099	CbGbCtD
Tamoxifen—ABCB11—Vincristine—hematologic cancer	0.00486	0.00973	CbGbCtD
Tamoxifen—ABCG2—Teniposide—hematologic cancer	0.0048	0.00961	CbGbCtD
Tamoxifen—CYP2A6—Ifosfamide—hematologic cancer	0.00479	0.00958	CbGbCtD
Tamoxifen—ESR2—ovarian follicle—hematologic cancer	0.00467	0.0948	CbGeAlD
Tamoxifen—CYP1A1—Thalidomide—hematologic cancer	0.00465	0.0093	CbGbCtD
Tamoxifen—ABCG2—Cladribine—hematologic cancer	0.0046	0.00922	CbGbCtD
Tamoxifen—ABCG2—Imatinib—hematologic cancer	0.00423	0.00847	CbGbCtD
Tamoxifen—CYP1A1—Dacarbazine—hematologic cancer	0.004	0.008	CbGbCtD
Tamoxifen—ABCG2—Nilotinib—hematologic cancer	0.00385	0.0077	CbGbCtD
Tamoxifen—CYP19A1—ovarian follicle—hematologic cancer	0.00368	0.0747	CbGeAlD
Tamoxifen—ABCB11—Dexamethasone—hematologic cancer	0.00366	0.00733	CbGbCtD
Tamoxifen—CYP1B1—Dexamethasone—hematologic cancer	0.00366	0.00733	CbGbCtD
Tamoxifen—CYP2E1—Thalidomide—hematologic cancer	0.00359	0.00718	CbGbCtD
Tamoxifen—CYP2C9—Bexarotene—hematologic cancer	0.0035	0.00701	CbGbCtD
Tamoxifen—ABCG2—Dasatinib—hematologic cancer	0.0034	0.00681	CbGbCtD
Tamoxifen—ABCB1—Lenalidomide—hematologic cancer	0.0034	0.0068	CbGbCtD
Tamoxifen—ABCG2—Mitoxantrone—hematologic cancer	0.00336	0.00672	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00327	0.00655	CbGbCtD
Tamoxifen—CYP3A7—Ifosfamide—hematologic cancer	0.00327	0.00655	CbGbCtD
Tamoxifen—ESR1—ovarian follicle—hematologic cancer	0.0032	0.0649	CbGeAlD
Tamoxifen—CYP2A6—Prednisolone—hematologic cancer	0.00319	0.00639	CbGbCtD
Tamoxifen—CYP1A1—Dasatinib—hematologic cancer	0.00314	0.00628	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00313	0.00626	CbGbCtD
Tamoxifen—CYP3A7—Imatinib—hematologic cancer	0.00313	0.00626	CbGbCtD
Tamoxifen—CYP2B6—Ifosfamide—hematologic cancer	0.00312	0.00624	CbGbCtD
Tamoxifen—CYP2E1—Dacarbazine—hematologic cancer	0.00309	0.00618	CbGbCtD
Tamoxifen—CYP2C8—Bortezomib—hematologic cancer	0.00308	0.00616	CbGbCtD
Tamoxifen—CYP3A5—Daunorubicin—hematologic cancer	0.00306	0.00613	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—hematologic cancer	0.00304	0.00608	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—hematologic cancer	0.00304	0.00608	CbGbCtD
Tamoxifen—CYP2D6—Lomustine—hematologic cancer	0.00298	0.00596	CbGbCtD
Tamoxifen—CYP19A1—Dexamethasone—hematologic cancer	0.00297	0.00594	CbGbCtD
Tamoxifen—CYP1A2—Carmustine—hematologic cancer	0.00295	0.0059	CbGbCtD
Tamoxifen—ABCC2—Irinotecan—hematologic cancer	0.00293	0.00585	CbGbCtD
Tamoxifen—CYP2C9—Idarubicin—hematologic cancer	0.0029	0.00581	CbGbCtD
Tamoxifen—CYP3A5—Thalidomide—hematologic cancer	0.00279	0.00558	CbGbCtD
Tamoxifen—CYP2B6—Nilotinib—hematologic cancer	0.00271	0.00542	CbGbCtD
Tamoxifen—CYP3A5—Teniposide—hematologic cancer	0.00266	0.00533	CbGbCtD
Tamoxifen—CYP2D6—Idarubicin—hematologic cancer	0.00265	0.00531	CbGbCtD
Tamoxifen—ABCG2—Irinotecan—hematologic cancer	0.00264	0.00529	CbGbCtD
Tamoxifen—ABCC2—Vinblastine—hematologic cancer	0.0026	0.00521	CbGbCtD
Tamoxifen—CYP2C19—Bortezomib—hematologic cancer	0.00258	0.00517	CbGbCtD
Tamoxifen—ABCC2—Vincristine—hematologic cancer	0.00256	0.00512	CbGbCtD
Tamoxifen—CYP1A2—Methoxsalen—hematologic cancer	0.00251	0.00501	CbGbCtD
Tamoxifen—CYP3A5—Ifosfamide—hematologic cancer	0.00246	0.00491	CbGbCtD
Tamoxifen—CYP2E1—Mitoxantrone—hematologic cancer	0.0024	0.00479	CbGbCtD
Tamoxifen—ABCC2—Cisplatin—hematologic cancer	0.00238	0.00477	CbGbCtD
Tamoxifen—CYP1A2—Bortezomib—hematologic cancer	0.00238	0.00477	CbGbCtD
Tamoxifen—CYP2C8—Ifosfamide—hematologic cancer	0.00236	0.00473	CbGbCtD
Tamoxifen—CYP3A5—Imatinib—hematologic cancer	0.00235	0.0047	CbGbCtD
Tamoxifen—ABCC2—Etoposide—hematologic cancer	0.00234	0.00469	CbGbCtD
Tamoxifen—ABCG2—Vincristine—hematologic cancer	0.00231	0.00463	CbGbCtD
Tamoxifen—CYP1A2—Daunorubicin—hematologic cancer	0.00228	0.00456	CbGbCtD
Tamoxifen—CYP2D6—Hydroxyurea—hematologic cancer	0.00226	0.00452	CbGbCtD
Tamoxifen—CYP2C19—Thalidomide—hematologic cancer	0.00225	0.0045	CbGbCtD
Tamoxifen—CYP1A2—Alitretinoin—hematologic cancer	0.00223	0.00447	CbGbCtD
Tamoxifen—ABCG2—Cisplatin—hematologic cancer	0.00216	0.00431	CbGbCtD
Tamoxifen—CYP2C9—Bortezomib—hematologic cancer	0.00215	0.0043	CbGbCtD
Tamoxifen—CYP2C19—Teniposide—hematologic cancer	0.00215	0.0043	CbGbCtD
Tamoxifen—ABCG2—Etoposide—hematologic cancer	0.00212	0.00424	CbGbCtD
Tamoxifen—CYP1A2—Thalidomide—hematologic cancer	0.00208	0.00415	CbGbCtD
Tamoxifen—CYP2C8—Nilotinib—hematologic cancer	0.00205	0.0041	CbGbCtD
Tamoxifen—CYP3A4—Bexarotene—hematologic cancer	0.00204	0.00408	CbGbCtD
Tamoxifen—ABCB1—Daunorubicin—hematologic cancer	0.00199	0.00399	CbGbCtD
Tamoxifen—CYP2C19—Ifosfamide—hematologic cancer	0.00198	0.00396	CbGbCtD
Tamoxifen—CYP2D6—Bortezomib—hematologic cancer	0.00196	0.00393	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00195	0.00391	CbGbCtD
Tamoxifen—CYP3A7—Irinotecan—hematologic cancer	0.00195	0.00391	CbGbCtD
Tamoxifen—ABCB1—Alitretinoin—hematologic cancer	0.00195	0.00391	CbGbCtD
Tamoxifen—ABCC2—Dexamethasone—hematologic cancer	0.00193	0.00386	CbGbCtD
Tamoxifen—CYP3A4—Busulfan—hematologic cancer	0.00189	0.00379	CbGbCtD
Tamoxifen—CYP3A4—Lomustine—hematologic cancer	0.00189	0.00379	CbGbCtD
Tamoxifen—CYP2C19—Imatinib—hematologic cancer	0.00189	0.00379	CbGbCtD
Tamoxifen—CYP3A5—Dasatinib—hematologic cancer	0.00188	0.00377	CbGbCtD
Tamoxifen—CYP2A6—Dexamethasone—hematologic cancer	0.00188	0.00377	CbGbCtD
Tamoxifen—CYP2C9—Thalidomide—hematologic cancer	0.00187	0.00374	CbGbCtD
Tamoxifen—CYP2B6—Irinotecan—hematologic cancer	0.00186	0.00372	CbGbCtD
Tamoxifen—CYP1A2—Dacarbazine—hematologic cancer	0.00179	0.00357	CbGbCtD
Tamoxifen—CYP2C9—Teniposide—hematologic cancer	0.00178	0.00357	CbGbCtD
Tamoxifen—CYP1A2—Imatinib—hematologic cancer	0.00175	0.00349	CbGbCtD
Tamoxifen—ABCG2—Dexamethasone—hematologic cancer	0.00174	0.00349	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00171	0.00342	CbGbCtD
Tamoxifen—CYP3A7—Vincristine—hematologic cancer	0.00171	0.00342	CbGbCtD
Tamoxifen—CYP3A4—Thiotepa—hematologic cancer	0.00169	0.00338	CbGbCtD
Tamoxifen—CYP2C9—Ifosfamide—hematologic cancer	0.00165	0.0033	CbGbCtD
Tamoxifen—CYP1A1—Dexamethasone—hematologic cancer	0.00161	0.00322	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—hematologic cancer	0.0016	0.0032	CbGbCtD
Tamoxifen—CYP2C9—Imatinib—hematologic cancer	0.00157	0.00315	CbGbCtD
Tamoxifen—ABCC2—Methotrexate—hematologic cancer	0.00155	0.0031	CbGbCtD
Tamoxifen—ABCB1—Imatinib—hematologic cancer	0.00153	0.00306	CbGbCtD
Tamoxifen—CYP2B6—Cisplatin—hematologic cancer	0.00152	0.00303	CbGbCtD
Tamoxifen—CYP2E1—Etoposide—hematologic cancer	0.00151	0.00302	CbGbCtD
Tamoxifen—CYP3A5—Irinotecan—hematologic cancer	0.00147	0.00293	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—hematologic cancer	0.00144	0.00289	CbGbCtD
Tamoxifen—CYP2D6—Imatinib—hematologic cancer	0.00144	0.00288	CbGbCtD
Tamoxifen—CYP2C9—Nilotinib—hematologic cancer	0.00143	0.00286	CbGbCtD
Tamoxifen—CYP1A2—Dasatinib—hematologic cancer	0.0014	0.00281	CbGbCtD
Tamoxifen—ABCG2—Methotrexate—hematologic cancer	0.0014	0.0028	CbGbCtD
Tamoxifen—ABCB1—Nilotinib—hematologic cancer	0.00139	0.00278	CbGbCtD
Tamoxifen—ABCB1—Vinorelbine—hematologic cancer	0.00138	0.00275	CbGbCtD
Tamoxifen—SULT1A1—hematopoietic system—hematologic cancer	0.00134	0.0272	CbGeAlD
Tamoxifen—CYP3A4—Methoxsalen—hematologic cancer	0.00131	0.00263	CbGbCtD
Tamoxifen—CYP2D6—Nilotinib—hematologic cancer	0.00131	0.00262	CbGbCtD
Tamoxifen—CYP2D6—Vinorelbine—hematologic cancer	0.0013	0.00259	CbGbCtD
Tamoxifen—CYP3A7—Dexamethasone—hematologic cancer	0.00129	0.00257	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00129	0.00257	CbGbCtD
Tamoxifen—CYP3A5—Vincristine—hematologic cancer	0.00128	0.00256	CbGbCtD
Tamoxifen—CYP3A4—Bortezomib—hematologic cancer	0.00125	0.0025	CbGbCtD
Tamoxifen—CYP2C19—Prednisone—hematologic cancer	0.00125	0.0025	CbGbCtD
Tamoxifen—CYP2E1—Dexamethasone—hematologic cancer	0.00124	0.00249	CbGbCtD
Tamoxifen—ABCB1—Dasatinib—hematologic cancer	0.00123	0.00245	CbGbCtD
Tamoxifen—CYP2B6—Dexamethasone—hematologic cancer	0.00122	0.00245	CbGbCtD
Tamoxifen—ABCB1—Mitoxantrone—hematologic cancer	0.00121	0.00242	CbGbCtD
Tamoxifen—CYP3A4—Daunorubicin—hematologic cancer	0.00119	0.00239	CbGbCtD
Tamoxifen—CYP3A5—Etoposide—hematologic cancer	0.00117	0.00235	CbGbCtD
Tamoxifen—UGT1A4—hematopoietic system—hematologic cancer	0.00117	0.0238	CbGeAlD
Tamoxifen—CYP2C8—Etoposide—hematologic cancer	0.00113	0.00226	CbGbCtD
Tamoxifen—ABCB1—Betamethasone—hematologic cancer	0.00108	0.00216	CbGbCtD
Tamoxifen—ABCB1—Gemcitabine—hematologic cancer	0.00107	0.00214	CbGbCtD
Tamoxifen—ABCB1—Prednisolone—hematologic cancer	0.00107	0.00213	CbGbCtD
Tamoxifen—CYP3A4—Cytarabine—hematologic cancer	0.00105	0.00211	CbGbCtD
Tamoxifen—CYP3A4—Teniposide—hematologic cancer	0.00104	0.00208	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—hematologic cancer	0.00102	0.00203	CbGbCtD
Tamoxifen—ABCB1—Prednisone—hematologic cancer	0.00101	0.00201	CbGbCtD
Tamoxifen—EBPL—lung—hematologic cancer	0.000981	0.0199	CbGeAlD
Tamoxifen—CYP3A5—Dexamethasone—hematologic cancer	0.000965	0.00193	CbGbCtD
Tamoxifen—CYP3A4—Ifosfamide—hematologic cancer	0.000958	0.00192	CbGbCtD
Tamoxifen—DHCR7—hematopoietic system—hematologic cancer	0.000955	0.0194	CbGeAlD
Tamoxifen—ABCB1—Irinotecan—hematologic cancer	0.000954	0.00191	CbGbCtD
Tamoxifen—CYP2C8—Dexamethasone—hematologic cancer	0.000928	0.00186	CbGbCtD
Tamoxifen—EBPL—testis—hematologic cancer	0.000926	0.0188	CbGeAlD
Tamoxifen—CYP3A4—Imatinib—hematologic cancer	0.000915	0.00183	CbGbCtD
Tamoxifen—SULT1A1—blood—hematologic cancer	0.000889	0.018	CbGeAlD
Tamoxifen—CYP1A2—Etoposide—hematologic cancer	0.000874	0.00175	CbGbCtD
Tamoxifen—CYP3A4—Ruxolitinib—hematologic cancer	0.000861	0.00172	CbGbCtD
Tamoxifen—ABCB1—Vinblastine—hematologic cancer	0.000848	0.0017	CbGbCtD
Tamoxifen—ABCB1—Vincristine—hematologic cancer	0.000834	0.00167	CbGbCtD
Tamoxifen—CYP3A4—Nilotinib—hematologic cancer	0.000831	0.00166	CbGbCtD
Tamoxifen—CYP3A4—Vinorelbine—hematologic cancer	0.000824	0.00165	CbGbCtD
Tamoxifen—CYP2C9—Cisplatin—hematologic cancer	0.000801	0.0016	CbGbCtD
Tamoxifen—CYP2D6—Vinblastine—hematologic cancer	0.000799	0.0016	CbGbCtD
Tamoxifen—SULT1A1—lung—hematologic cancer	0.000779	0.0158	CbGeAlD
Tamoxifen—CYP2C19—Dexamethasone—hematologic cancer	0.000778	0.00156	CbGbCtD
Tamoxifen—ABCB1—Cisplatin—hematologic cancer	0.000777	0.00156	CbGbCtD
Tamoxifen—UGT1A4—blood—hematologic cancer	0.000776	0.0157	CbGeAlD
Tamoxifen—ABCB1—Etoposide—hematologic cancer	0.000764	0.00153	CbGbCtD
Tamoxifen—CYP3A4—Triamcinolone—hematologic cancer	0.000754	0.00151	CbGbCtD
Tamoxifen—SULT1A1—testis—hematologic cancer	0.000735	0.0149	CbGeAlD
Tamoxifen—CYP3A4—Dasatinib—hematologic cancer	0.000735	0.00147	CbGbCtD
Tamoxifen—DHCR7—gonad—hematologic cancer	0.000726	0.0147	CbGeAlD
Tamoxifen—CYP3A4—Mitoxantrone—hematologic cancer	0.000726	0.00145	CbGbCtD
Tamoxifen—EBPL—lymph node—hematologic cancer	0.000671	0.0136	CbGeAlD
Tamoxifen—CES1—hematopoietic system—hematologic cancer	0.000651	0.0132	CbGeAlD
Tamoxifen—CYP2C9—Dexamethasone—hematologic cancer	0.000647	0.0013	CbGbCtD
Tamoxifen—CYP3A4—Betamethasone—hematologic cancer	0.000647	0.00129	CbGbCtD
Tamoxifen—CYP3A4—Prednisolone—hematologic cancer	0.000638	0.00128	CbGbCtD
Tamoxifen—DHCR7—blood—hematologic cancer	0.000632	0.0128	CbGeAlD
Tamoxifen—ABCB1—Dexamethasone—hematologic cancer	0.000628	0.00126	CbGbCtD
Tamoxifen—ESRRA—blood—hematologic cancer	0.000623	0.0126	CbGeAlD
Tamoxifen—DHCR7—bone marrow—hematologic cancer	0.000612	0.0124	CbGeAlD
Tamoxifen—CYP3A4—Prednisone—hematologic cancer	0.000603	0.00121	CbGbCtD
Tamoxifen—ESRRA—bone marrow—hematologic cancer	0.000602	0.0122	CbGeAlD
Tamoxifen—CYP2D6—Dexamethasone—hematologic cancer	0.000592	0.00118	CbGbCtD
Tamoxifen—CYP3A4—Irinotecan—hematologic cancer	0.000571	0.00114	CbGbCtD
Tamoxifen—ESR2—hematopoietic system—hematologic cancer	0.000564	0.0114	CbGeAlD
Tamoxifen—DHCR7—lung—hematologic cancer	0.000554	0.0112	CbGeAlD
Tamoxifen—FMO1—lung—hematologic cancer	0.000554	0.0112	CbGeAlD
Tamoxifen—ESRRA—lung—hematologic cancer	0.000546	0.0111	CbGeAlD
Tamoxifen—SULT1A1—lymph node—hematologic cancer	0.000533	0.0108	CbGeAlD
Tamoxifen—DHCR7—testis—hematologic cancer	0.000523	0.0106	CbGeAlD
Tamoxifen—ABCB1—Doxorubicin—hematologic cancer	0.000521	0.00104	CbGbCtD
Tamoxifen—ESRRA—testis—hematologic cancer	0.000515	0.0104	CbGeAlD
Tamoxifen—CYP3A4—Vinblastine—hematologic cancer	0.000508	0.00102	CbGbCtD
Tamoxifen—ABCB1—Methotrexate—hematologic cancer	0.000505	0.00101	CbGbCtD
Tamoxifen—CYP3A4—Vincristine—hematologic cancer	0.000499	0.001	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—hematologic cancer	0.000491	0.000982	CbGbCtD
Tamoxifen—FMO3—lung—hematologic cancer	0.000479	0.00972	CbGeAlD
Tamoxifen—CYP3A4—Etoposide—hematologic cancer	0.000458	0.000916	CbGbCtD
Tamoxifen—ABCB11—testis—hematologic cancer	0.000457	0.00928	CbGeAlD
Tamoxifen—FMO3—testis—hematologic cancer	0.000452	0.00917	CbGeAlD
Tamoxifen—CYP19A1—hematopoietic system—hematologic cancer	0.000444	0.00902	CbGeAlD
Tamoxifen—CES1—blood—hematologic cancer	0.000432	0.00875	CbGeAlD
Tamoxifen—ESR2—gonad—hematologic cancer	0.000429	0.0087	CbGeAlD
Tamoxifen—CYP1B1—hematopoietic system—hematologic cancer	0.000415	0.00843	CbGeAlD
Tamoxifen—ESR1—hematopoietic system—hematologic cancer	0.000386	0.00784	CbGeAlD
Tamoxifen—DHCR7—lymph node—hematologic cancer	0.000379	0.00769	CbGeAlD
Tamoxifen—FMO1—lymph node—hematologic cancer	0.000379	0.00769	CbGeAlD
Tamoxifen—CES1—lung—hematologic cancer	0.000378	0.00767	CbGeAlD
Tamoxifen—CYP3A4—Dexamethasone—hematologic cancer	0.000376	0.000753	CbGbCtD
Tamoxifen—ESR2—blood—hematologic cancer	0.000374	0.00758	CbGeAlD
Tamoxifen—ESRRA—lymph node—hematologic cancer	0.000373	0.00757	CbGeAlD
Tamoxifen—CYP2C19—hematopoietic system—hematologic cancer	0.000365	0.0074	CbGeAlD
Tamoxifen—CES1—testis—hematologic cancer	0.000357	0.00724	CbGeAlD
Tamoxifen—CYP19A1—gonad—hematologic cancer	0.000338	0.00686	CbGeAlD
Tamoxifen—CYP2A6—lung—hematologic cancer	0.000329	0.00668	CbGeAlD
Tamoxifen—FMO3—lymph node—hematologic cancer	0.000328	0.00665	CbGeAlD
Tamoxifen—ESR2—lung—hematologic cancer	0.000328	0.00664	CbGeAlD
Tamoxifen—CYP2C8—hematopoietic system—hematologic cancer	0.000318	0.00645	CbGeAlD
Tamoxifen—CYP1B1—gonad—hematologic cancer	0.000316	0.00641	CbGeAlD
Tamoxifen—CYP3A4—Doxorubicin—hematologic cancer	0.000312	0.000625	CbGbCtD
Tamoxifen—ESR2—testis—hematologic cancer	0.000309	0.00627	CbGeAlD
Tamoxifen—CYP1A2—hematopoietic system—hematologic cancer	0.000298	0.00604	CbGeAlD
Tamoxifen—CYP19A1—blood—hematologic cancer	0.000294	0.00597	CbGeAlD
Tamoxifen—CYP1A1—hematopoietic system—hematologic cancer	0.000294	0.00596	CbGeAlD
Tamoxifen—ESR1—gonad—hematologic cancer	0.000294	0.00596	CbGeAlD
Tamoxifen—SIGMAR1—blood—hematologic cancer	0.000289	0.00587	CbGeAlD
Tamoxifen—CYP3A5—hematopoietic system—hematologic cancer	0.000287	0.00583	CbGeAlD
Tamoxifen—CYP2B6—hematopoietic system—hematologic cancer	0.000285	0.00579	CbGeAlD
Tamoxifen—CYP2C9—hematopoietic system—hematologic cancer	0.000283	0.00573	CbGeAlD
Tamoxifen—ABCC2—blood—hematologic cancer	0.000281	0.0057	CbGeAlD
Tamoxifen—SIGMAR1—bone marrow—hematologic cancer	0.00028	0.00568	CbGeAlD
Tamoxifen—CYP1B1—blood—hematologic cancer	0.000275	0.00558	CbGeAlD
Tamoxifen—CYP2E1—hematopoietic system—hematologic cancer	0.000268	0.00543	CbGeAlD
Tamoxifen—CES1—lymph node—hematologic cancer	0.000259	0.00525	CbGeAlD
Tamoxifen—ESR1—blood—hematologic cancer	0.000256	0.00519	CbGeAlD
Tamoxifen—SIGMAR1—lung—hematologic cancer	0.000254	0.00515	CbGeAlD
Tamoxifen—CYP19A1—testis—hematologic cancer	0.000244	0.00494	CbGeAlD
Tamoxifen—CYP2C19—blood—hematologic cancer	0.000242	0.0049	CbGeAlD
Tamoxifen—CYP1B1—lung—hematologic cancer	0.000241	0.0049	CbGeAlD
Tamoxifen—EBP—Azacitidine—Pentostatin—hematologic cancer	0.000241	0.192	CbGdCrCtD
Tamoxifen—SIGMAR1—testis—hematologic cancer	0.000239	0.00486	CbGeAlD
Tamoxifen—ABCC2—testis—hematologic cancer	0.000232	0.00472	CbGeAlD
Tamoxifen—CYP1B1—testis—hematologic cancer	0.000228	0.00462	CbGeAlD
Tamoxifen—ESR1—lung—hematologic cancer	0.000224	0.00455	CbGeAlD
Tamoxifen—ESR2—lymph node—hematologic cancer	0.000224	0.00454	CbGeAlD
Tamoxifen—CYP2B6—gonad—hematologic cancer	0.000217	0.0044	CbGeAlD
Tamoxifen—CYP3A4—hematopoietic system—hematologic cancer	0.000216	0.00437	CbGeAlD
Tamoxifen—EBP—Azacitidine—Clofarabine—hematologic cancer	0.000215	0.171	CbGdCrCtD
Tamoxifen—CYP2D6—hematopoietic system—hematologic cancer	0.000212	0.0043	CbGeAlD
Tamoxifen—ESR1—testis—hematologic cancer	0.000212	0.00429	CbGeAlD
Tamoxifen—CYP2C8—blood—hematologic cancer	0.000211	0.00428	CbGeAlD
Tamoxifen—ABCG2—blood—hematologic cancer	0.000205	0.00416	CbGeAlD
Tamoxifen—EBP—Azacitidine—Nelarabine—hematologic cancer	0.000202	0.16	CbGdCrCtD
Tamoxifen—ABCG2—bone marrow—hematologic cancer	0.000198	0.00402	CbGeAlD
Tamoxifen—CYP1A2—blood—hematologic cancer	0.000197	0.004	CbGeAlD
Tamoxifen—CYP1A1—blood—hematologic cancer	0.000195	0.00395	CbGeAlD
Tamoxifen—CYP3A5—blood—hematologic cancer	0.00019	0.00386	CbGeAlD
Tamoxifen—CYP2B6—blood—hematologic cancer	0.000189	0.00384	CbGeAlD
Tamoxifen—CYP2C9—blood—hematologic cancer	0.000187	0.0038	CbGeAlD
Tamoxifen—Diethylstilbestrol—ABCG2—hematologic cancer	0.000181	0.148	CrCbGaD
Tamoxifen—ABCG2—lung—hematologic cancer	0.00018	0.00365	CbGeAlD
Tamoxifen—CYP2E1—blood—hematologic cancer	0.000177	0.0036	CbGeAlD
Tamoxifen—Diethylstilbestrol—ESR1—hematologic cancer	0.000177	0.145	CrCbGaD
Tamoxifen—CYP19A1—lymph node—hematologic cancer	0.000177	0.00358	CbGeAlD
Tamoxifen—CYP2C8—testis—hematologic cancer	0.000174	0.00354	CbGeAlD
Tamoxifen—SIGMAR1—lymph node—hematologic cancer	0.000174	0.00352	CbGeAlD
Tamoxifen—CYP1A2—lung—hematologic cancer	0.000173	0.00351	CbGeAlD
Tamoxifen—Ospemifene—ESR1—hematologic cancer	0.000172	0.141	CrCbGaD
Tamoxifen—CYP1A1—lung—hematologic cancer	0.000171	0.00346	CbGeAlD
Tamoxifen—ABCG2—testis—hematologic cancer	0.00017	0.00344	CbGeAlD
Tamoxifen—ABCC2—lymph node—hematologic cancer	0.000169	0.00342	CbGeAlD
Tamoxifen—CYP3A5—lung—hematologic cancer	0.000167	0.00338	CbGeAlD
Tamoxifen—CYP2B6—lung—hematologic cancer	0.000166	0.00336	CbGeAlD
Tamoxifen—CYP1B1—lymph node—hematologic cancer	0.000165	0.00335	CbGeAlD
Tamoxifen—EBP—Azacitidine—Fludarabine—hematologic cancer	0.000157	0.125	CbGdCrCtD
Tamoxifen—CYP2B6—testis—hematologic cancer	0.000156	0.00317	CbGeAlD
Tamoxifen—CYP2E1—lung—hematologic cancer	0.000156	0.00316	CbGeAlD
Tamoxifen—ESR1—lymph node—hematologic cancer	0.000153	0.00311	CbGeAlD
Tamoxifen—ABCB1—hematopoietic system—hematologic cancer	0.000153	0.00309	CbGeAlD
Tamoxifen—EBP—Azacitidine—Cytarabine—hematologic cancer	0.000149	0.118	CbGdCrCtD
Tamoxifen—EBP—Azacitidine—Gemcitabine—hematologic cancer	0.000149	0.118	CbGdCrCtD
Tamoxifen—CYP2E1—testis—hematologic cancer	0.000147	0.00298	CbGeAlD
Tamoxifen—EBP—Azacitidine—Cladribine—hematologic cancer	0.000145	0.115	CbGdCrCtD
Tamoxifen—CYP3A4—blood—hematologic cancer	0.000143	0.0029	CbGeAlD
Tamoxifen—CYP2D6—blood—hematologic cancer	0.000141	0.00285	CbGeAlD
Tamoxifen—Toremifene—ESR1—hematologic cancer	0.00014	0.115	CrCbGaD
Tamoxifen—ABCG2—lymph node—hematologic cancer	0.000123	0.00249	CbGeAlD
Tamoxifen—Clomifene—ESR1—hematologic cancer	0.000121	0.0995	CrCbGaD
Tamoxifen—CYP1A1—lymph node—hematologic cancer	0.000117	0.00237	CbGeAlD
Tamoxifen—CYP2D6—testis—hematologic cancer	0.000116	0.00236	CbGeAlD
Tamoxifen—ABCB1—gonad—hematologic cancer	0.000116	0.00235	CbGeAlD
Tamoxifen—ABCB1—blood—hematologic cancer	0.000101	0.00205	CbGeAlD
Tamoxifen—Phenoxybenzamine—SLC22A1—hematologic cancer	0.0001	0.0823	CrCbGaD
Tamoxifen—ABCB1—bone marrow—hematologic cancer	9.78e-05	0.00198	CbGeAlD
Tamoxifen—ABCB1—lung—hematologic cancer	8.86e-05	0.0018	CbGeAlD
Tamoxifen—Diphenhydramine—SLC22A1—hematologic cancer	8.42e-05	0.069	CrCbGaD
Tamoxifen—ABCB1—testis—hematologic cancer	8.36e-05	0.0017	CbGeAlD
Tamoxifen—Diethylstilbestrol—ABCB1—hematologic cancer	7.53e-05	0.0617	CrCbGaD
Tamoxifen—ABCB1—lymph node—hematologic cancer	6.06e-05	0.00123	CbGeAlD
Tamoxifen—Toremifene—ABCB1—hematologic cancer	5.97e-05	0.0489	CrCbGaD
Tamoxifen—Clomifene—ABCB1—hematologic cancer	5.16e-05	0.0423	CrCbGaD
Tamoxifen—Loperamide—ABCB1—hematologic cancer	3.32e-05	0.0272	CrCbGaD
Tamoxifen—Methadone—ABCB1—hematologic cancer	2.36e-05	0.0194	CrCbGaD
Tamoxifen—Rash—Mitoxantrone—hematologic cancer	1.25e-05	7.58e-05	CcSEcCtD
Tamoxifen—Rash—Irinotecan—hematologic cancer	1.25e-05	7.58e-05	CcSEcCtD
Tamoxifen—Dermatitis—Mitoxantrone—hematologic cancer	1.24e-05	7.57e-05	CcSEcCtD
Tamoxifen—Dermatitis—Irinotecan—hematologic cancer	1.24e-05	7.57e-05	CcSEcCtD
Tamoxifen—Headache—Mitoxantrone—hematologic cancer	1.24e-05	7.53e-05	CcSEcCtD
Tamoxifen—Headache—Irinotecan—hematologic cancer	1.24e-05	7.53e-05	CcSEcCtD
Tamoxifen—Nausea—Ifosfamide—hematologic cancer	1.24e-05	7.52e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.23e-05	7.49e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.23e-05	7.49e-05	CcSEcCtD
Tamoxifen—Myalgia—Prednisone—hematologic cancer	1.23e-05	7.47e-05	CcSEcCtD
Tamoxifen—Arthralgia—Prednisone—hematologic cancer	1.23e-05	7.47e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Cisplatin—hematologic cancer	1.23e-05	7.47e-05	CcSEcCtD
Tamoxifen—Erythema multiforme—Epirubicin—hematologic cancer	1.23e-05	7.46e-05	CcSEcCtD
Tamoxifen—Anxiety—Prednisone—hematologic cancer	1.22e-05	7.45e-05	CcSEcCtD
Tamoxifen—Alopecia—Methotrexate—hematologic cancer	1.22e-05	7.45e-05	CcSEcCtD
Tamoxifen—Vomiting—Gemcitabine—hematologic cancer	1.22e-05	7.44e-05	CcSEcCtD
Tamoxifen—Insomnia—Betamethasone—hematologic cancer	1.22e-05	7.44e-05	CcSEcCtD
Tamoxifen—Insomnia—Dexamethasone—hematologic cancer	1.22e-05	7.44e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Dexamethasone—hematologic cancer	1.21e-05	7.39e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Betamethasone—hematologic cancer	1.21e-05	7.39e-05	CcSEcCtD
Tamoxifen—Discomfort—Prednisone—hematologic cancer	1.21e-05	7.38e-05	CcSEcCtD
Tamoxifen—Rash—Gemcitabine—hematologic cancer	1.21e-05	7.38e-05	CcSEcCtD
Tamoxifen—Dermatitis—Gemcitabine—hematologic cancer	1.21e-05	7.37e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Etoposide—hematologic cancer	1.21e-05	7.36e-05	CcSEcCtD
Tamoxifen—Erythema—Methotrexate—hematologic cancer	1.21e-05	7.34e-05	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—hematologic cancer	1.21e-05	7.33e-05	CcSEcCtD
Tamoxifen—Headache—Gemcitabine—hematologic cancer	1.21e-05	7.33e-05	CcSEcCtD
Tamoxifen—Nausea—Vincristine—hematologic cancer	1.21e-05	7.33e-05	CcSEcCtD
Tamoxifen—Flushing—Epirubicin—hematologic cancer	1.2e-05	7.32e-05	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—hematologic cancer	1.2e-05	7.3e-05	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—hematologic cancer	1.2e-05	7.3e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisolone—hematologic cancer	1.19e-05	7.26e-05	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—hematologic cancer	1.19e-05	7.26e-05	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—hematologic cancer	1.19e-05	7.24e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Dexamethasone—hematologic cancer	1.19e-05	7.24e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Betamethasone—hematologic cancer	1.19e-05	7.24e-05	CcSEcCtD
Tamoxifen—Urticaria—Triamcinolone—hematologic cancer	1.18e-05	7.2e-05	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—hematologic cancer	1.18e-05	7.19e-05	CcSEcCtD
Tamoxifen—Dysgeusia—Methotrexate—hematologic cancer	1.18e-05	7.18e-05	CcSEcCtD
Tamoxifen—Asthenia—Etoposide—hematologic cancer	1.18e-05	7.17e-05	CcSEcCtD
Tamoxifen—Oedema—Prednisone—hematologic cancer	1.18e-05	7.16e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Betamethasone—hematologic cancer	1.18e-05	7.15e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Dexamethasone—hematologic cancer	1.18e-05	7.15e-05	CcSEcCtD
Tamoxifen—Nausea—Irinotecan—hematologic cancer	1.17e-05	7.14e-05	CcSEcCtD
Tamoxifen—Nausea—Mitoxantrone—hematologic cancer	1.17e-05	7.14e-05	CcSEcCtD
Tamoxifen—Infection—Prednisone—hematologic cancer	1.17e-05	7.12e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.17e-05	7.1e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.17e-05	7.1e-05	CcSEcCtD
Tamoxifen—Back pain—Methotrexate—hematologic cancer	1.17e-05	7.1e-05	CcSEcCtD
Tamoxifen—Fatigue—Betamethasone—hematologic cancer	1.17e-05	7.09e-05	CcSEcCtD
Tamoxifen—Fatigue—Dexamethasone—hematologic cancer	1.17e-05	7.09e-05	CcSEcCtD
Tamoxifen—Pruritus—Etoposide—hematologic cancer	1.16e-05	7.07e-05	CcSEcCtD
Tamoxifen—Arrhythmia—Epirubicin—hematologic cancer	1.16e-05	7.05e-05	CcSEcCtD
Tamoxifen—Pain—Dexamethasone—hematologic cancer	1.16e-05	7.03e-05	CcSEcCtD
Tamoxifen—Pain—Betamethasone—hematologic cancer	1.16e-05	7.03e-05	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—hematologic cancer	1.16e-05	7.03e-05	CcSEcCtD
Tamoxifen—Alopecia—Epirubicin—hematologic cancer	1.15e-05	6.97e-05	CcSEcCtD
Tamoxifen—Nausea—Gemcitabine—hematologic cancer	1.14e-05	6.95e-05	CcSEcCtD
Tamoxifen—Vomiting—Cisplatin—hematologic cancer	1.14e-05	6.94e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Prednisone—hematologic cancer	1.14e-05	6.93e-05	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—hematologic cancer	1.13e-05	6.9e-05	CcSEcCtD
Tamoxifen—Rash—Cisplatin—hematologic cancer	1.13e-05	6.88e-05	CcSEcCtD
Tamoxifen—Dermatitis—Cisplatin—hematologic cancer	1.13e-05	6.87e-05	CcSEcCtD
Tamoxifen—Erythema—Epirubicin—hematologic cancer	1.13e-05	6.87e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Etoposide—hematologic cancer	1.12e-05	6.84e-05	CcSEcCtD
Tamoxifen—Anorexia—Prednisone—hematologic cancer	1.12e-05	6.83e-05	CcSEcCtD
Tamoxifen—Anaemia—Methotrexate—hematologic cancer	1.12e-05	6.78e-05	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—hematologic cancer	1.11e-05	6.77e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Betamethasone—hematologic cancer	1.11e-05	6.73e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.11e-05	6.73e-05	CcSEcCtD
Tamoxifen—Dysgeusia—Epirubicin—hematologic cancer	1.11e-05	6.72e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Triamcinolone—hematologic cancer	1.1e-05	6.68e-05	CcSEcCtD
Tamoxifen—Back pain—Epirubicin—hematologic cancer	1.09e-05	6.64e-05	CcSEcCtD
Tamoxifen—Dizziness—Etoposide—hematologic cancer	1.09e-05	6.61e-05	CcSEcCtD
Tamoxifen—Muscle spasms—Epirubicin—hematologic cancer	1.09e-05	6.6e-05	CcSEcCtD
Tamoxifen—Leukopenia—Methotrexate—hematologic cancer	1.08e-05	6.57e-05	CcSEcCtD
Tamoxifen—Urticaria—Dexamethasone—hematologic cancer	1.07e-05	6.54e-05	CcSEcCtD
Tamoxifen—Urticaria—Betamethasone—hematologic cancer	1.07e-05	6.54e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.07e-05	6.53e-05	CcSEcCtD
Tamoxifen—Dizziness—Prednisolone—hematologic cancer	1.07e-05	6.52e-05	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—hematologic cancer	1.07e-05	6.52e-05	CcSEcCtD
Tamoxifen—Asthenia—Triamcinolone—hematologic cancer	1.07e-05	6.5e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Dexamethasone—hematologic cancer	1.07e-05	6.5e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Betamethasone—hematologic cancer	1.07e-05	6.5e-05	CcSEcCtD
Tamoxifen—Nausea—Cisplatin—hematologic cancer	1.07e-05	6.48e-05	CcSEcCtD
Tamoxifen—Insomnia—Prednisone—hematologic cancer	1.07e-05	6.48e-05	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—hematologic cancer	1.06e-05	6.45e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Prednisone—hematologic cancer	1.06e-05	6.43e-05	CcSEcCtD
Tamoxifen—Pruritus—Triamcinolone—hematologic cancer	1.05e-05	6.41e-05	CcSEcCtD
Tamoxifen—Cough—Methotrexate—hematologic cancer	1.05e-05	6.4e-05	CcSEcCtD
Tamoxifen—Vomiting—Etoposide—hematologic cancer	1.05e-05	6.36e-05	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—hematologic cancer	1.04e-05	6.35e-05	CcSEcCtD
Tamoxifen—Anaemia—Epirubicin—hematologic cancer	1.04e-05	6.35e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Prednisone—hematologic cancer	1.04e-05	6.31e-05	CcSEcCtD
Tamoxifen—Rash—Etoposide—hematologic cancer	1.04e-05	6.3e-05	CcSEcCtD
Tamoxifen—Dermatitis—Etoposide—hematologic cancer	1.04e-05	6.3e-05	CcSEcCtD
Tamoxifen—Headache—Etoposide—hematologic cancer	1.03e-05	6.26e-05	CcSEcCtD
Tamoxifen—Myalgia—Methotrexate—hematologic cancer	1.03e-05	6.25e-05	CcSEcCtD
Tamoxifen—Arthralgia—Methotrexate—hematologic cancer	1.03e-05	6.25e-05	CcSEcCtD
Tamoxifen—Chest pain—Methotrexate—hematologic cancer	1.03e-05	6.25e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Prednisone—hematologic cancer	1.02e-05	6.23e-05	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—hematologic cancer	1.02e-05	6.22e-05	CcSEcCtD
Tamoxifen—Rash—Prednisolone—hematologic cancer	1.02e-05	6.22e-05	CcSEcCtD
Tamoxifen—Dermatitis—Prednisolone—hematologic cancer	1.02e-05	6.21e-05	CcSEcCtD
Tamoxifen—Fatigue—Prednisone—hematologic cancer	1.02e-05	6.18e-05	CcSEcCtD
Tamoxifen—Headache—Prednisolone—hematologic cancer	1.02e-05	6.18e-05	CcSEcCtD
Tamoxifen—Discomfort—Methotrexate—hematologic cancer	1.01e-05	6.17e-05	CcSEcCtD
Tamoxifen—Leukopenia—Epirubicin—hematologic cancer	1.01e-05	6.15e-05	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—hematologic cancer	1.01e-05	6.14e-05	CcSEcCtD
Tamoxifen—Constipation—Prednisone—hematologic cancer	1.01e-05	6.13e-05	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—hematologic cancer	1e-05	6.11e-05	CcSEcCtD
Tamoxifen—Dizziness—Triamcinolone—hematologic cancer	9.86e-06	6e-05	CcSEcCtD
Tamoxifen—Cough—Epirubicin—hematologic cancer	9.85e-06	5.99e-05	CcSEcCtD
Tamoxifen—Infection—Methotrexate—hematologic cancer	9.78e-06	5.95e-05	CcSEcCtD
Tamoxifen—Nausea—Etoposide—hematologic cancer	9.76e-06	5.94e-05	CcSEcCtD
Tamoxifen—Hypertension—Epirubicin—hematologic cancer	9.75e-06	5.93e-05	CcSEcCtD
Tamoxifen—Asthenia—Dexamethasone—hematologic cancer	9.71e-06	5.9e-05	CcSEcCtD
Tamoxifen—Asthenia—Betamethasone—hematologic cancer	9.71e-06	5.9e-05	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—hematologic cancer	9.66e-06	5.87e-05	CcSEcCtD
Tamoxifen—Thrombocytopenia—Methotrexate—hematologic cancer	9.64e-06	5.86e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Prednisone—hematologic cancer	9.63e-06	5.86e-05	CcSEcCtD
Tamoxifen—Nausea—Prednisolone—hematologic cancer	9.63e-06	5.86e-05	CcSEcCtD
Tamoxifen—Chest pain—Epirubicin—hematologic cancer	9.61e-06	5.84e-05	CcSEcCtD
Tamoxifen—Arthralgia—Epirubicin—hematologic cancer	9.61e-06	5.84e-05	CcSEcCtD
Tamoxifen—Myalgia—Epirubicin—hematologic cancer	9.61e-06	5.84e-05	CcSEcCtD
Tamoxifen—Anxiety—Epirubicin—hematologic cancer	9.58e-06	5.82e-05	CcSEcCtD
Tamoxifen—Pruritus—Dexamethasone—hematologic cancer	9.57e-06	5.82e-05	CcSEcCtD
Tamoxifen—Pruritus—Betamethasone—hematologic cancer	9.57e-06	5.82e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methotrexate—hematologic cancer	9.52e-06	5.79e-05	CcSEcCtD
Tamoxifen—Discomfort—Epirubicin—hematologic cancer	9.5e-06	5.77e-05	CcSEcCtD
Tamoxifen—Vomiting—Triamcinolone—hematologic cancer	9.48e-06	5.76e-05	CcSEcCtD
Tamoxifen—Rash—Triamcinolone—hematologic cancer	9.4e-06	5.72e-05	CcSEcCtD
Tamoxifen—Dry mouth—Epirubicin—hematologic cancer	9.4e-06	5.72e-05	CcSEcCtD
Tamoxifen—Dermatitis—Triamcinolone—hematologic cancer	9.39e-06	5.71e-05	CcSEcCtD
Tamoxifen—Anorexia—Methotrexate—hematologic cancer	9.39e-06	5.71e-05	CcSEcCtD
Tamoxifen—Urticaria—Prednisone—hematologic cancer	9.36e-06	5.69e-05	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—hematologic cancer	9.35e-06	5.69e-05	CcSEcCtD
Tamoxifen—Headache—Triamcinolone—hematologic cancer	9.34e-06	5.68e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Prednisone—hematologic cancer	9.31e-06	5.66e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Dexamethasone—hematologic cancer	9.26e-06	5.63e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Betamethasone—hematologic cancer	9.26e-06	5.63e-05	CcSEcCtD
Tamoxifen—Oedema—Epirubicin—hematologic cancer	9.21e-06	5.6e-05	CcSEcCtD
Tamoxifen—Infection—Epirubicin—hematologic cancer	9.15e-06	5.57e-05	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—hematologic cancer	9.12e-06	5.54e-05	CcSEcCtD
Tamoxifen—Thrombocytopenia—Epirubicin—hematologic cancer	9.02e-06	5.49e-05	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—hematologic cancer	9.02e-06	5.48e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.97e-06	5.45e-05	CcSEcCtD
Tamoxifen—Dizziness—Betamethasone—hematologic cancer	8.95e-06	5.44e-05	CcSEcCtD
Tamoxifen—Dizziness—Dexamethasone—hematologic cancer	8.95e-06	5.44e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Epirubicin—hematologic cancer	8.91e-06	5.42e-05	CcSEcCtD
Tamoxifen—Insomnia—Methotrexate—hematologic cancer	8.91e-06	5.42e-05	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—hematologic cancer	8.89e-06	5.41e-05	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—hematologic cancer	8.89e-06	5.41e-05	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—hematologic cancer	8.89e-06	5.41e-05	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—hematologic cancer	8.86e-06	5.39e-05	CcSEcCtD
Tamoxifen—Nausea—Triamcinolone—hematologic cancer	8.86e-06	5.39e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Methotrexate—hematologic cancer	8.84e-06	5.38e-05	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—hematologic cancer	8.79e-06	5.34e-05	CcSEcCtD
Tamoxifen—Anorexia—Epirubicin—hematologic cancer	8.78e-06	5.34e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Methotrexate—hematologic cancer	8.78e-06	5.34e-05	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—hematologic cancer	8.7e-06	5.29e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisone—hematologic cancer	8.68e-06	5.28e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Methotrexate—hematologic cancer	8.67e-06	5.27e-05	CcSEcCtD
Tamoxifen—Vomiting—Dexamethasone—hematologic cancer	8.6e-06	5.23e-05	CcSEcCtD
Tamoxifen—Vomiting—Betamethasone—hematologic cancer	8.6e-06	5.23e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Methotrexate—hematologic cancer	8.56e-06	5.2e-05	CcSEcCtD
Tamoxifen—Rash—Dexamethasone—hematologic cancer	8.53e-06	5.19e-05	CcSEcCtD
Tamoxifen—Rash—Betamethasone—hematologic cancer	8.53e-06	5.19e-05	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—hematologic cancer	8.53e-06	5.18e-05	CcSEcCtD
Tamoxifen—Dermatitis—Dexamethasone—hematologic cancer	8.52e-06	5.18e-05	CcSEcCtD
Tamoxifen—Dermatitis—Betamethasone—hematologic cancer	8.52e-06	5.18e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Methotrexate—hematologic cancer	8.5e-06	5.17e-05	CcSEcCtD
Tamoxifen—Fatigue—Methotrexate—hematologic cancer	8.49e-06	5.16e-05	CcSEcCtD
Tamoxifen—Headache—Betamethasone—hematologic cancer	8.47e-06	5.15e-05	CcSEcCtD
Tamoxifen—Headache—Dexamethasone—hematologic cancer	8.47e-06	5.15e-05	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—hematologic cancer	8.47e-06	5.15e-05	CcSEcCtD
Tamoxifen—Asthenia—Prednisone—hematologic cancer	8.45e-06	5.14e-05	CcSEcCtD
Tamoxifen—Pain—Methotrexate—hematologic cancer	8.42e-06	5.12e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.39e-06	5.1e-05	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—hematologic cancer	8.35e-06	5.08e-05	CcSEcCtD
Tamoxifen—Pruritus—Prednisone—hematologic cancer	8.34e-06	5.07e-05	CcSEcCtD
Tamoxifen—Insomnia—Epirubicin—hematologic cancer	8.33e-06	5.07e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Epirubicin—hematologic cancer	8.27e-06	5.03e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—hematologic cancer	8.24e-06	5.01e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Epirubicin—hematologic cancer	8.21e-06	5e-05	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—hematologic cancer	8.13e-06	4.94e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Epirubicin—hematologic cancer	8.11e-06	4.93e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Prednisone—hematologic cancer	8.06e-06	4.9e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methotrexate—hematologic cancer	8.05e-06	4.9e-05	CcSEcCtD
Tamoxifen—Nausea—Betamethasone—hematologic cancer	8.04e-06	4.89e-05	CcSEcCtD
Tamoxifen—Nausea—Dexamethasone—hematologic cancer	8.04e-06	4.89e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Epirubicin—hematologic cancer	8.01e-06	4.87e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.95e-06	4.84e-05	CcSEcCtD
Tamoxifen—Fatigue—Epirubicin—hematologic cancer	7.94e-06	4.83e-05	CcSEcCtD
Tamoxifen—Pain—Epirubicin—hematologic cancer	7.88e-06	4.79e-05	CcSEcCtD
Tamoxifen—Constipation—Epirubicin—hematologic cancer	7.88e-06	4.79e-05	CcSEcCtD
Tamoxifen—Urticaria—Methotrexate—hematologic cancer	7.82e-06	4.76e-05	CcSEcCtD
Tamoxifen—Dizziness—Prednisone—hematologic cancer	7.79e-06	4.74e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Methotrexate—hematologic cancer	7.78e-06	4.73e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.77e-06	4.72e-05	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—hematologic cancer	7.71e-06	4.69e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—hematologic cancer	7.66e-06	4.66e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—hematologic cancer	7.6e-06	4.62e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Epirubicin—hematologic cancer	7.53e-06	4.58e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—hematologic cancer	7.5e-06	4.56e-05	CcSEcCtD
Tamoxifen—Vomiting—Prednisone—hematologic cancer	7.49e-06	4.56e-05	CcSEcCtD
Tamoxifen—Rash—Prednisone—hematologic cancer	7.43e-06	4.52e-05	CcSEcCtD
Tamoxifen—Dermatitis—Prednisone—hematologic cancer	7.42e-06	4.51e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—hematologic cancer	7.41e-06	4.51e-05	CcSEcCtD
Tamoxifen—Headache—Prednisone—hematologic cancer	7.38e-06	4.49e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—hematologic cancer	7.36e-06	4.48e-05	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—hematologic cancer	7.35e-06	4.47e-05	CcSEcCtD
Tamoxifen—Urticaria—Epirubicin—hematologic cancer	7.32e-06	4.45e-05	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—hematologic cancer	7.29e-06	4.43e-05	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—hematologic cancer	7.29e-06	4.43e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Epirubicin—hematologic cancer	7.28e-06	4.43e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Methotrexate—hematologic cancer	7.25e-06	4.41e-05	CcSEcCtD
Tamoxifen—Asthenia—Methotrexate—hematologic cancer	7.06e-06	4.3e-05	CcSEcCtD
Tamoxifen—Nausea—Prednisone—hematologic cancer	7e-06	4.26e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.97e-06	4.24e-05	CcSEcCtD
Tamoxifen—Pruritus—Methotrexate—hematologic cancer	6.97e-06	4.24e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Epirubicin—hematologic cancer	6.79e-06	4.13e-05	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—hematologic cancer	6.77e-06	4.12e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—hematologic cancer	6.74e-06	4.1e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Methotrexate—hematologic cancer	6.74e-06	4.1e-05	CcSEcCtD
Tamoxifen—Asthenia—Epirubicin—hematologic cancer	6.61e-06	4.02e-05	CcSEcCtD
Tamoxifen—Pruritus—Epirubicin—hematologic cancer	6.52e-06	3.96e-05	CcSEcCtD
Tamoxifen—Dizziness—Methotrexate—hematologic cancer	6.51e-06	3.96e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Epirubicin—hematologic cancer	6.3e-06	3.83e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—hematologic cancer	6.28e-06	3.82e-05	CcSEcCtD
Tamoxifen—Vomiting—Methotrexate—hematologic cancer	6.26e-06	3.81e-05	CcSEcCtD
Tamoxifen—Rash—Methotrexate—hematologic cancer	6.21e-06	3.78e-05	CcSEcCtD
Tamoxifen—Dermatitis—Methotrexate—hematologic cancer	6.2e-06	3.77e-05	CcSEcCtD
Tamoxifen—Headache—Methotrexate—hematologic cancer	6.17e-06	3.75e-05	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—hematologic cancer	6.12e-06	3.72e-05	CcSEcCtD
Tamoxifen—Dizziness—Epirubicin—hematologic cancer	6.09e-06	3.71e-05	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—hematologic cancer	6.03e-06	3.67e-05	CcSEcCtD
Tamoxifen—Vomiting—Epirubicin—hematologic cancer	5.86e-06	3.56e-05	CcSEcCtD
Tamoxifen—Nausea—Methotrexate—hematologic cancer	5.85e-06	3.56e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—hematologic cancer	5.83e-06	3.55e-05	CcSEcCtD
Tamoxifen—Rash—Epirubicin—hematologic cancer	5.81e-06	3.53e-05	CcSEcCtD
Tamoxifen—Dermatitis—Epirubicin—hematologic cancer	5.8e-06	3.53e-05	CcSEcCtD
Tamoxifen—Headache—Epirubicin—hematologic cancer	5.77e-06	3.51e-05	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—hematologic cancer	5.64e-06	3.43e-05	CcSEcCtD
Tamoxifen—Nausea—Epirubicin—hematologic cancer	5.47e-06	3.33e-05	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—hematologic cancer	5.42e-06	3.3e-05	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—hematologic cancer	5.38e-06	3.27e-05	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—hematologic cancer	5.37e-06	3.27e-05	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—hematologic cancer	5.34e-06	3.25e-05	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—hematologic cancer	5.06e-06	3.08e-05	CcSEcCtD
Tamoxifen—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.23e-06	1.53e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.23e-06	1.53e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYCS—hematologic cancer	1.23e-06	1.52e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTPN11—hematologic cancer	1.23e-06	1.52e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.22e-06	1.52e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.22e-06	1.52e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.22e-06	1.51e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.21e-06	1.51e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.21e-06	1.51e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3R1—hematologic cancer	1.21e-06	1.51e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.2e-06	1.49e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3R1—hematologic cancer	1.2e-06	1.49e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CREB1—hematologic cancer	1.19e-06	1.48e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.18e-06	1.47e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.18e-06	1.47e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MTHFR—hematologic cancer	1.18e-06	1.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.17e-06	1.46e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BRAF—hematologic cancer	1.17e-06	1.46e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CD—hematologic cancer	1.17e-06	1.45e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCL2—hematologic cancer	1.16e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6R—hematologic cancer	1.16e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTP1—hematologic cancer	1.16e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CREBBP—hematologic cancer	1.16e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—hematologic cancer	1.15e-06	1.43e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NUP98—hematologic cancer	1.14e-06	1.42e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—hematologic cancer	1.14e-06	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.12e-06	1.39e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CB—hematologic cancer	1.12e-06	1.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CB—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CD44—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NQO1—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAP2K1—hematologic cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NUP214—hematologic cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTEN—hematologic cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3R1—hematologic cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CD—hematologic cancer	1.1e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.1e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MAPK3—hematologic cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.08e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTR—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CG—hematologic cancer	1.07e-06	1.33e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NCOR1—hematologic cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTM1—hematologic cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTEN—hematologic cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO2—hematologic cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—hematologic cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—EP300—hematologic cancer	1.05e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGF2—hematologic cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—hematologic cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYCS—hematologic cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3R1—hematologic cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.03e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—hematologic cancer	1.03e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.03e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.02e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CB—hematologic cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—EP300—hematologic cancer	1.01e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JAK2—hematologic cancer	1.01e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SDC1—hematologic cancer	1e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—hematologic cancer	1e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NCOR1—hematologic cancer	1e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NCOR1—hematologic cancer	9.93e-07	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—hematologic cancer	9.93e-07	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CREBBP—hematologic cancer	9.92e-07	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—hematologic cancer	9.88e-07	1.23e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MDM2—hematologic cancer	9.82e-07	1.22e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CREBBP—hematologic cancer	9.72e-07	1.21e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CREBBP—hematologic cancer	9.7e-07	1.2e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTEN—hematologic cancer	9.67e-07	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—hematologic cancer	9.62e-07	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTEN—hematologic cancer	9.58e-07	1.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CB—hematologic cancer	9.56e-07	1.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MTOR—hematologic cancer	9.56e-07	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.5e-07	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CD—hematologic cancer	9.41e-07	1.17e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—hematologic cancer	9.39e-07	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.37e-07	1.16e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—hematologic cancer	9.29e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—hematologic cancer	9.23e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—EP300—hematologic cancer	9.22e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CD—hematologic cancer	9.21e-07	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CD—hematologic cancer	9.19e-07	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CREBBP—hematologic cancer	9.16e-07	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—EP300—hematologic cancer	9.14e-07	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—hematologic cancer	9.1e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—hematologic cancer	9.08e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—hematologic cancer	9.06e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1B—hematologic cancer	8.97e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.93e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3R1—hematologic cancer	8.88e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—hematologic cancer	8.85e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—hematologic cancer	8.79e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTEN—hematologic cancer	8.78e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—hematologic cancer	8.78e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—hematologic cancer	8.78e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCB1—hematologic cancer	8.74e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3R1—hematologic cancer	8.7e-07	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CD—hematologic cancer	8.69e-07	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3R1—hematologic cancer	8.68e-07	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—hematologic cancer	8.57e-07	1.07e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—hematologic cancer	8.56e-07	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CD44—hematologic cancer	8.54e-07	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NQO1—hematologic cancer	8.54e-07	1.06e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JUN—hematologic cancer	8.54e-07	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NCOR1—hematologic cancer	8.48e-07	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—hematologic cancer	8.48e-07	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.48e-07	1.05e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—hematologic cancer	8.43e-07	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CREBBP—hematologic cancer	8.4e-07	1.04e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—EP300—hematologic cancer	8.37e-07	1.04e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1A—hematologic cancer	8.28e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTEN—hematologic cancer	8.26e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3R1—hematologic cancer	8.2e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CB—hematologic cancer	8.2e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—hematologic cancer	8.09e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYCS—hematologic cancer	8.08e-07	1e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK8—hematologic cancer	8.08e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	8.03e-07	9.98e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CB—hematologic cancer	8.03e-07	9.98e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CB—hematologic cancer	8.01e-07	9.96e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CD—hematologic cancer	7.96e-07	9.9e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—hematologic cancer	7.89e-07	9.81e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EP300—hematologic cancer	7.88e-07	9.79e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—hematologic cancer	7.86e-07	9.77e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—hematologic cancer	7.78e-07	9.67e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.73e-07	9.61e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SRC—hematologic cancer	7.66e-07	9.52e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CB—hematologic cancer	7.57e-07	9.41e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3R1—hematologic cancer	7.52e-07	9.34e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—hematologic cancer	7.5e-07	9.32e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CREBBP—hematologic cancer	7.5e-07	9.31e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—hematologic cancer	7.49e-07	9.31e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—hematologic cancer	7.46e-07	9.27e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—hematologic cancer	7.44e-07	9.24e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—hematologic cancer	7.39e-07	9.18e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—hematologic cancer	7.37e-07	9.16e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—hematologic cancer	7.37e-07	9.15e-06	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—hematologic cancer	7.32e-07	9.1e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CREBBP—hematologic cancer	7.32e-07	9.09e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—hematologic cancer	7.13e-07	8.85e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CD—hematologic cancer	7.11e-07	8.83e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTEN—hematologic cancer	7.08e-07	8.8e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK3—hematologic cancer	7.06e-07	8.77e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—hematologic cancer	7.02e-07	8.72e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CB—hematologic cancer	6.94e-07	8.62e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTEN—hematologic cancer	6.94e-07	8.62e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CD—hematologic cancer	6.94e-07	8.62e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTEN—hematologic cancer	6.92e-07	8.6e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CREBBP—hematologic cancer	6.9e-07	8.57e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—hematologic cancer	6.86e-07	8.53e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—hematologic cancer	6.85e-07	8.51e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—hematologic cancer	6.85e-07	8.51e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CREBBP—hematologic cancer	6.84e-07	8.49e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—hematologic cancer	6.82e-07	8.47e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—hematologic cancer	6.76e-07	8.4e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—EP300—hematologic cancer	6.76e-07	8.4e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.75e-07	8.38e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3R1—hematologic cancer	6.71e-07	8.34e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—EP300—hematologic cancer	6.62e-07	8.22e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.61e-07	8.21e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—EP300—hematologic cancer	6.6e-07	8.21e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3R1—hematologic cancer	6.55e-07	8.14e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.55e-07	8.14e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.55e-07	8.14e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTEN—hematologic cancer	6.54e-07	8.13e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CD—hematologic cancer	6.54e-07	8.12e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CD—hematologic cancer	6.48e-07	8.05e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—hematologic cancer	6.45e-07	8.02e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—hematologic cancer	6.4e-07	7.95e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—hematologic cancer	6.36e-07	7.9e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—hematologic cancer	6.34e-07	7.88e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—hematologic cancer	6.3e-07	7.83e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—EP300—hematologic cancer	6.24e-07	7.75e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CB—hematologic cancer	6.2e-07	7.7e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—hematologic cancer	6.19e-07	7.7e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3R1—hematologic cancer	6.17e-07	7.67e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—hematologic cancer	6.12e-07	7.61e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3R1—hematologic cancer	6.12e-07	7.6e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CB—hematologic cancer	6.05e-07	7.51e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTEN—hematologic cancer	6e-07	7.45e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CREBBP—hematologic cancer	5.84e-07	7.26e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	5.83e-07	7.24e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.79e-07	7.19e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—EP300—hematologic cancer	5.72e-07	7.11e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CB—hematologic cancer	5.7e-07	7.08e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CB—hematologic cancer	5.65e-07	7.02e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—hematologic cancer	5.64e-07	7e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—hematologic cancer	5.57e-07	6.92e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CD—hematologic cancer	5.54e-07	6.88e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—hematologic cancer	5.52e-07	6.86e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—hematologic cancer	5.47e-07	6.79e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—hematologic cancer	5.39e-07	6.7e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTEN—hematologic cancer	5.35e-07	6.65e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3R1—hematologic cancer	5.23e-07	6.5e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTEN—hematologic cancer	5.23e-07	6.49e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—hematologic cancer	5.16e-07	6.41e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—EP300—hematologic cancer	5.11e-07	6.34e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—hematologic cancer	5.06e-07	6.29e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—hematologic cancer	5e-07	6.21e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—EP300—hematologic cancer	4.98e-07	6.19e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTEN—hematologic cancer	4.92e-07	6.12e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—hematologic cancer	4.9e-07	6.08e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—hematologic cancer	4.89e-07	6.07e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTEN—hematologic cancer	4.88e-07	6.07e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.86e-07	6.04e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CB—hematologic cancer	4.83e-07	6e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—hematologic cancer	4.76e-07	5.91e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—EP300—hematologic cancer	4.7e-07	5.84e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—EP300—hematologic cancer	4.66e-07	5.78e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—hematologic cancer	4.62e-07	5.73e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.51e-07	5.6e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.27e-07	5.31e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—hematologic cancer	4.23e-07	5.26e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—hematologic cancer	4.22e-07	5.24e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTEN—hematologic cancer	4.17e-07	5.18e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—hematologic cancer	4.08e-07	5.07e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.04e-07	5.02e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—hematologic cancer	4e-07	4.97e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—hematologic cancer	3.99e-07	4.96e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—EP300—hematologic cancer	3.98e-07	4.94e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—hematologic cancer	3.78e-07	4.69e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—hematologic cancer	3.77e-07	4.68e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.73e-07	4.63e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—hematologic cancer	3.69e-07	4.58e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—hematologic cancer	3.47e-07	4.32e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—hematologic cancer	3.46e-07	4.3e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—hematologic cancer	3.44e-07	4.28e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTEN—hematologic cancer	3.22e-07	4e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—hematologic cancer	3.09e-07	3.83e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—EP300—hematologic cancer	3.07e-07	3.81e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—hematologic cancer	3.01e-07	3.74e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—hematologic cancer	2.94e-07	3.66e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—hematologic cancer	2.84e-07	3.53e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—hematologic cancer	2.81e-07	3.5e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—hematologic cancer	2.4e-07	2.99e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.27e-07	2.82e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—hematologic cancer	1.86e-07	2.31e-06	CbGpPWpGaD
